Dr. Ghabril has been a transplant hepatologist for over 10 years. He is currently an Associate Professor of Medicine and an integral member of the transplant team at Indiana University. His clinical experience is complemented by administrative and extensive quality work as director of an inpatient liver service. He serves on multiple multidisciplinary committees for safety, quality and utilization.

Dr. Ghabril received his medical degree from the Royal College of Surgeons in Ireland, completed his residency at Thomas Jefferson University Hospital in Philadelphia, and completed fellowships at the Mayo Clinic. He is ABIM Board Certified in Internal Medicine, Gastroenterology and Transplant Hepatology.

As of September 2024, Dr. Ghabril reported the following ongoing external relationships:

Funding for clinical trial expenses and staff, paid to the Indiana University School of Medicine, from the following company:

• Salix Pharmaceuticals

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:

• CymaBay
• Gilead Sciences
• National Institutes for Health Clinical Center
• Zydus Pharmaceuticals

Dr. Keaveny is a Consultant Hepatologist in the Departments of Transplant and Internal Medicine and Medical Director of the Liver Transplant Program at the Mayo Clinic in Jacksonville, Florida. He is an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science and ABIM Board Certified in Gastroenterology and Transplant Hepatology. Previously, Dr. Keaveny was a member of the Section of Gastroenterology in the Department of Medicine at Boston University Medical Center.

Dr. Keaveny has served on the ABIM Transplant Hepatology Item-Writing Task Force. He joined the Transplant Hepatology Traditional, 10-Year MOC Exam Approval Committee in 2023. He has served on several committees in the American Association for the Study of Liver Diseases and was Chair of the Education Committee from 2015 to 2017. He was a member of the Liver and Intestine Advisory Council of the American Society of Transplantation from 2008 to 2012. He was the Program Director for the Transplant Hepatology Fellowship at Mayo Clinic Florida (MCF) from 2008 to 2013. He has received awards for teaching from the MCF Division of Gastroenterology and Hepatology as well as the Internal Medicine Residency Program. He was recognized for his contributions to the Transplant Hepatology Fellowship by receiving the Outstanding Course Director Award in 2008 from the Mayo School of Continuous Professional Development. He is on the editorial boards of Hepatology, Liver Transplantation and Annals of Hepatology. He served as an Associate Editor of Clinical Liver Disease from 2011 to 2017. He is the author or coauthor of more than 60 peer-reviewed publications and edited the book, “Complications of Cirrhosis: Evaluation and Management” (2015).

Dr. Keaveny received his medical degree from University College Dublin in Ireland. He completed internal medicine residencies in both Dublin and Boston, and fellowships in gastroenterology and transplant hepatology at Boston University Medical Center and the Lahey Hospital & Medical Center (formerly the Lahey Clinic), respectively.

As of October 2024, Dr. Keaveny reported the following external relationships:

• UpToDate, receiving compensation for authorship.

Dr. Kwo is a Professor of Medicine and Director of Hepatology at Stanford University. He is ABIM Board Certified in Gastroenterology and Transplant Hepatology. Prior to joining the faculty at Stanford, Dr. Kwo served as Medical Director of Liver Transplantation at Indiana University.

Dr. Kwo is a Trustee of the American College of Gastroenterology and serves on the Clinical Research Committee for the American Association for the Study of Liver Diseases. He has won multiple awards at the university, local and national levels.

Dr. Kwo completed his undergraduate education at Oberlin College and his medical education at Wayne State University. He completed his internal medicine training at the University of Maryland Medical System and his gastroenterology and hepatology training at the Mayo Clinic.

As of May 2025, Dr. Kwo reported the following external relationships:

Funding for salary support, clinical trial expenses and staff, paid to Stanford University, from the following companies:

• 89Bio
• Akero
• Ausper
• Fractyl
• Gilead
• Janssen
• Madrigal
• Novo Nordisk
• Salix
• Takeda
• Target PhamaSolutions
• Ultragenyx

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:

• Mirum, without compensation.
• Precision Biosciences, without compensation.
• Tune Therapeutics, without compensation.

Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

• Aligos, for an advisory board.
• Arbutus Biopharma Corporation, for an advisory board.
• The CDA Foundation, for a grant review panel for viral hepatitis elimination.
• Gilead, for an advisory board for nonalcoholic steatohepatitis, hepatitis B and hepatitis C therapies.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation for travel expenses and/or honoraria:

• Amgen, for consulting on clinical trial design, receiving honoraria.
• Ausper, receiving honoraria.
• Durect, receiving honoraria.
• Genentech, for consulting on clinical trial design, receiving honoraria.
• Hepquant, without compensation.
• Inventia, receiving honoraria.
• Novo Nordisk, receiving honoraria.

Dr. McGuire is the Medical Director of Liver Transplantation at the University of Alabama at Birmingham (UAB). He is ABIM Board Certified in Gastroenterology and Transplant Hepatology. Dr. McGuire is Director of the UAB Liver Transplant Fellowship Program, a member on the Steering Committee for the UAB Gastroenterology Fellowship Program, a member of the School of Medicine Promotions Committee and a member of the Liver Transplant Evaluation Committee.

Nationally he has been an active volunteer for the United Network for Organ Sharing (UNOS), the American Society of Transplantation (AST) and the American Association for the Study of Liver Diseases (AASLD). For UNOS, he has been on the Membership and Standards Committee, the Region 3 Liver and Intestinal Representative, a Regional Review Board Member and a National Review Board Member. For AST, Dr. McGuire has been on the Nominating Committee, AST Practice Guidelines Committee and has chaired the Liver and Intestinal Advisory Group. For AASLD, he has been on the Acute on Chronic Liver Failure Special Interest Group and Ethics Committee.

After graduating from the University of Notre Dame, Dr. McGuire completed a Master of Science in Bioengineering at the Pennsylvania State University and a doctorate in medicine at the University of Pittsburgh. He completed internal medicine residency and gastroenterology and hepatology fellowships at the University of Minnesota.

As of June 2025, Dr. McGuire reported no ongoing external relationships.

American Board of Pediatrics (ABP)

Dr. Perito is an Associate Professor at the University of California, San Francisco (UCSF) who specializes in pediatric liver and pancreatic disease, pediatric liver transplant and pediatric gastroenterology. She is jointly appointed in the Departments of Pediatrics and Epidemiology and Biostatistics. She is ABP Board Certified in Pediatrics, Pediatric Gastroenterology and Pediatric Transplant Hepatology. Dr. Perito's clinical care and research focus on optimizing long-term outcomes for children with liver and pancreatic diseases. She is the Associate Medical Director of UCSF's multidisciplinary Pediatric Liver Transplant Team with expertise in the care of children with pediatric liver disease before and in the long term after transplant.

She leads epidemiologic research focused on improving access to transplants, organ allocation and waitlist outcomes for children awaiting liver transplant. She is a co-chair of the Starzl Network for Excellence in Pediatric Transplantation on improving the efficacy and reducing the burden of immunosuppression for children after liver transplant. She also advocates for children nationally as the Vice Chair of the UNOS Pediatric Transplantation Committee and Chair of the Society for Pediatric Liver Transplant's Advocacy Committee. She is also Co-Director of UCSF's Pediatric Pancreas Program. She leads UCSF's work in National Institutes of Health-sponsored multi-center trials including the INSPPIRE study on acute recurrent and chronic pancreatitis in children and adolescents.

As of September 2024, Dr. Perito reported the following ongoing external relationships:

• Service on a research-related expert panel or advisory board for the following company, with compensation for travel expenses and honoraria:
  Mirum
• Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with honoraria:
  Triveni Bio
• Dr. Perito serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
  The American Association for the Study of Liver Diseases, receiving compensation as Associate Editor of Liver Transplantation.
• Donor Network West, Board of Directors, without compensation.
• Starzi Network for Excellence in Pediatric Transplantation, Network Co-Chair, receiving honoraria and reimbursement for travel expenses.
• The United Network for Organ Sharing, Committee Member, receiving reimbursement for travel expenses.
   

American Board of Pediatrics (ABP)

Dr. Rand is a Professor of Pediatrics at the University of Pennsylvania School of Medicine and the Medical Director of the Liver Transplant Program at the Children's Hospital of Philadelphia. She is ABP Board Certified in Pediatric Gastroenterology and holds a Certificate of Added Qualification in Pediatric Advanced Transplant Hepatology.
Dr. Rand is involved in graduate medical education as a clinical faculty member and also as the Program Director of Pediatric Gastroenterology Fellowship and the advanced Pediatric Hepatology Training Program.

Dr. Rand is a graduate of the University of Chicago Pritzker School of Medicine and completed her residency in pediatrics at the Johns Hopkins Hospital in Baltimore, followed by her pediatric gastroenterology fellowship at the University of Chicago.

View my board certification status via ABMS Website.

As of September 2024, Dr. Rand reported no ongoing external relationships.